EGFR and neoplasm: We consistently found a clear biotinylation labeling of these cell entities in tissue sections (SI Appendix, Fig. S4A), and confocal microscopy of tumor SCSs could confirm distinct surface biotinylation of CD45+, CD68+, CD31+, and EGFR+ tumor cells (SI Appendix, Fig. S4B).